Physician profile
Colleen King
NPI 1629077649
$4,868.56
in general payments reported to CMS, 2019-2025
22 companies · $926 in 2025
The $926 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,280 · 2020: $333 · 2021: $429 · 2022: $318 · 2023: $1,096 · 2024: $487 · 2025: $926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,832 · Gift: $520 · Entertainment: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,831.70 |
| Gift | $520.00 |
| Entertainment | $158.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $959.90 | 2019-2025 | Precision7, Total30, Dailies |
| Visionary Optics LLC | $520.00 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $514.76 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $345.53 | 2019-2021 | |
| Abbvie INC. | $317.64 | 2022-2024 | |
| Coopervision INC. | $315.11 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $271.99 | 2022-2025 | Infuse |
| Maculogix, INC. | $270.11 | 2019 | |
| Horizon Therapeutics Plc | $231.15 | 2023 | Tepezza |
| Sight Sciences, INC. | $202.57 | 2020-2023 | Omni Surgical System |
| Optos, INC. | $158.09 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $147.74 | 2019-2021 | |
| Shire North American Group INC | $130.90 | 2019 | |
| Lkc Technologies, INC. | $125.98 | 2023 | |
| Allergan, INC. | $117.52 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $66.96 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $47.79 | 2024 | Tecnis Iol |
| Notal Vision, INC. | $47.40 | 2024 | Foresee Home |
| Harrow Eye, LLC | $24.00 | 2024 | Vevye |
| Novartis Pharmaceuticals Corporation | $23.78 | 2021 | |
| Medline Industries LP | $15.12 | 2025 | |
| Oyster Point Pharma, INC. | $14.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.